- Home
- SSY vs CPHI Comparison
SSY vs CPHI Comparison
Compare SSY & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSY
- CPHI
- Stock Information
- Founded
- SSY 1959
- CPHI N/A
- Country
- SSY United States
- CPHI China
- Employees
- SSY N/A
- CPHI N/A
- Industry
- SSY Hospital/Nursing Management
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- SSY Health Care
- CPHI Health Care
- Exchange
- SSY Nasdaq
- CPHI Nasdaq
- Market Cap
- SSY 6.3M
- CPHI 7.3M
- IPO Year
- SSY N/A
- CPHI N/A
- Fundamental
- Price
- SSY $0.88
- CPHI $1.61
- Analyst Decision
- SSY
- CPHI
- Analyst Count
- SSY 0
- CPHI 0
- Target Price
- SSY N/A
- CPHI N/A
- AVG Volume (30 Days)
- SSY 58.7K
- CPHI 62.7K
- Earning Date
- SSY 05-13-2025
- CPHI 05-14-2025
- Dividend Yield
- SSY N/A
- CPHI N/A
- EPS Growth
- SSY N/A
- CPHI N/A
- EPS
- SSY 0.25
- CPHI N/A
- Revenue
- SSY $31,094,000.00
- CPHI $4,295,377.00
- Revenue This Year
- SSY N/A
- CPHI N/A
- Revenue Next Year
- SSY N/A
- CPHI N/A
- P/E Ratio
- SSY $3.55
- CPHI N/A
- Revenue Growth
- SSY N/A
- CPHI N/A
- 52 Week Low
- SSY $0.59
- CPHI $1.20
- 52 Week High
- SSY $1.91
- CPHI $3.35
- Technical
- Relative Strength Index (RSI)
- SSY 50.23
- CPHI 39.31
- Support Level
- SSY $0.85
- CPHI $1.56
- Resistance Level
- SSY $0.94
- CPHI $1.75
- Average True Range (ATR)
- SSY 0.06
- CPHI 0.27
- MACD
- SSY 0.00
- CPHI -0.07
- Stochastic Oscillator
- SSY 39.00
- CPHI 13.42
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.